Suppr超能文献

功能性和无功能促肾上腺皮质垂体腺瘤中 miRNA 表达的差异表明 miRNA 在调节皮质类固醇受体中的作用。

Difference in miRNA Expression in Functioning and Silent Corticotroph Pituitary Adenomas Indicates the Role of miRNA in the Regulation of Corticosteroid Receptors.

机构信息

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

出版信息

Int J Mol Sci. 2022 Mar 5;23(5):2867. doi: 10.3390/ijms23052867.

Abstract

Corticotroph pituitary adenomas commonly cause Cushing's disease (CD), but some of them are clinically silent. The reason why they do not cause endocrinological symptoms remains unclear. We used data from small RNA sequencing in adenomas causing CD ( = 28) and silent ones ( = 20) to explore the role of miRNA in hormone secretion and clinical status of the tumors. By comparing miRNA profiles, we identified 19 miRNAs differentially expressed in clinically functioning and silent corticotroph adenomas. The analysis of their putative target genes indicates a role of miRNAs in regulation of the corticosteroid receptors expression. Adenomas causing CD have higher expression of hsa-miR-124-3p and hsa-miR-135-5p and lower expression of their target genes and . The role of hsa-miR-124-3p in the regulation of was further validated in vitro using AtT-20/D16v-F2 cells. The cells transfected with miR-124-3p mimics showed lower levels of glucocorticoid receptor expression than control cells while the interaction between miR-124-3p and 3' UTR was confirmed using luciferase reporter assay. The results indicate a relatively small difference in miRNA expression between clinically functioning and silent corticotroph pituitary adenomas. High expression of hsa-miR-124-3p in adenomas causing CD plays a role in the regulation of glucocorticoid receptor level and probably in reducing the effect of negative feedback mediated by corticosteroids.

摘要

促肾上腺皮质激素垂体腺瘤常导致库欣病(CD),但其中一些是临床无症状的。它们不引起内分泌症状的原因尚不清楚。我们使用导致 CD 的腺瘤(=28)和无症状腺瘤(=20)中的小 RNA 测序数据来探讨 miRNA 在激素分泌和肿瘤临床状态中的作用。通过比较 miRNA 图谱,我们鉴定了在临床上有功能和无功能的促肾上腺皮质激素腺瘤中差异表达的 19 个 miRNA。对其假定靶基因的分析表明 miRNA 在调节皮质类固醇受体表达中的作用。导致 CD 的腺瘤具有更高表达的 hsa-miR-124-3p 和 hsa-miR-135-5p,以及其靶基因 和 的更低表达。hsa-miR-124-3p 在调节 中的作用在体外使用 AtT-20/D16v-F2 细胞进一步得到验证。转染 miR-124-3p 模拟物的细胞显示出比对照细胞更低水平的糖皮质激素受体表达,而 miR-124-3p 和 3'UTR 之间的相互作用则通过荧光素酶报告基因测定得到证实。结果表明,临床上有功能和无功能的促肾上腺皮质激素垂体腺瘤之间的 miRNA 表达差异相对较小。导致 CD 的腺瘤中 hsa-miR-124-3p 的高表达在调节糖皮质激素受体水平中发挥作用,可能在降低皮质类固醇介导的负反馈作用方面发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验